Effects of Immunosuppressants on Receptor Activator of NF-κB Ligand and Osteoprotegerin Production by Human Osteoblastic and Coronary Artery Smooth Muscle Cells
- 12 January 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 280 (1), 334-339
- https://doi.org/10.1006/bbrc.2000.4130
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cyclosporine, but not FK506, selectively induces renal and coronary artery smooth muscle contractionSurgery, 1998
- TacrolimusDrugs, 1997
- Post-transplantation bone disease: The role of immunosuppressive agents and the skeletonJournal of Bone and Mineral Research, 1996
- RAPAMYCIN INHIBITS TRANSPLANT VASCULOPATHY IN LONG-SURVIVING RAT HEART ALLOGRAFTSTransplantation, 1995
- Rapamycin: A bone sparing immunosuppressant?Journal of Bone and Mineral Research, 1995
- New Issues in Therapy after Renal TransplantationNew England Journal of Medicine, 1994
- THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVOTransplantation, 1994
- Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in ratsCalcified Tissue International, 1993
- Cyclosporin a: Friend or foe?Calcified Tissue International, 1991
- Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorptionJournal of Bone and Mineral Research, 1989